Short time infusion of bevacizumab in combination with 5FU-based chemotherapy as first-line therapy in a non-selective patient group with metastatic colorectal cancer

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Acta oncologica 2010-01, Vol.49 (3), p.395-396
Hauptverfasser:	Dohn, Line H., Jensen, Benny V., Larsen, Finn O.
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiogenesis Inhibitors - administration & dosage Antibodies, Monoclonal - administration & dosage Antibodies, Monoclonal, Humanized Antineoplastic Combined Chemotherapy Protocols - administration & dosage Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bevacizumab Camptothecin - administration & dosage Camptothecin - analogs & derivatives Capecitabine Colorectal Neoplasms - drug therapy Colorectal Neoplasms - mortality Colorectal Neoplasms - pathology Deoxycytidine - administration & dosage Deoxycytidine - analogs & derivatives Drug Administration Schedule Feasibility Studies Fluorouracil - administration & dosage Fluorouracil - analogs & derivatives Humans Infusions, Intravenous Leucovorin - administration & dosage Organoplatinum Compounds - administration & dosage Retrospective Studies Survival Analysis Time Factors Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!